Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

3.5K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.5K
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

627
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
627
Hormonal Regulation01:33

Hormonal Regulation

35.5K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
35.5K
Hypertension I: Introduction01:28

Hypertension I: Introduction

585
Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
585
Hormonal Regulation of Blood Pressure01:17

Hormonal Regulation of Blood Pressure

5.6K
Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
5.6K
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

379
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
379

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Stroke prevention in the Americas: from knowing to doing.

Lancet regional health. Americas·2026
Same author

Family history of diabetes in first-degree relatives and risk of hand surgical diagnoses: a Swedish population-based cohort study from the Malmö Diet and Cancer Study.

BMJ open·2026
Same author

Childhood cancer survivors with premature ovarian insufficiency have low bone mineral density at long term follow-up.

Bone·2026
Same author

Hypertension in autoimmune rheumatic diseases: a position paper from the European Society of Hypertension working group on small arteries. Part A: pathophysiology, prevalence and cardiovascular risk estimation.

Journal of hypertension·2026
Same author

Hypertension in autoimmune rheumatic diseases - a position paper from the European Society of Hypertension working group on small arteries. Part B: Recommendations for the clinical management of hypertension.

Journal of hypertension·2026
Same author

Pragmatic trial assessing polygenic risk driven statin therapy for cardiovascular disease prevention: study protocol for the EE-PRS trial.

BMJ open·2026

Related Experiment Video

Updated: Dec 26, 2025

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug
05:57

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug

Published on: May 17, 2024

1.1K

Hypertension and Reproduction.

Peter M Nilsson1,2, Margus Viigimaa3, Aleksander Giwercman4

  • 1Department of Clinical Sciences, Lund University, Lund, Sweden. Peter.Nilsson@med.lu.se.

Current Hypertension Reports
|March 15, 2020
PubMed
Summary
This summary is machine-generated.

Reproductive health factors, from fetal growth to menopause, are linked to hypertension and cardiovascular disease risk. Understanding these connections can improve disease prediction and prevention strategies.

Keywords:
Assisted reproductive technologiesErectile dysfunctionHypertensive disorders in pregnancyLow birth weightMale hypogonadismOral contraception

More Related Videos

Assessing Murine Resistance Artery Function Using Pressure Myography
07:25

Assessing Murine Resistance Artery Function Using Pressure Myography

Published on: June 7, 2013

22.9K
A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis
08:21

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis

Published on: October 26, 2020

5.4K

Related Experiment Videos

Last Updated: Dec 26, 2025

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug
05:57

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug

Published on: May 17, 2024

1.1K
Assessing Murine Resistance Artery Function Using Pressure Myography
07:25

Assessing Murine Resistance Artery Function Using Pressure Myography

Published on: June 7, 2013

22.9K
A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis
08:21

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis

Published on: October 26, 2020

5.4K

Area of Science:

  • Reproductive Endocrinology
  • Cardiovascular Health
  • Metabolic Syndrome

Background:

  • Reproductive life stages and health issues are increasingly recognized as significant contributors to cardiovascular disease (CVD) risk.
  • Factors such as impaired fetal growth, male hypogonadism, and hypertensive disorders of pregnancy are associated with long-term cardiovascular complications.

Purpose of the Study:

  • To review reproductive life factors that increase the risk of hypertension and cardiovascular disease in men and women.
  • To explore the impact of early life programming, sexual health, and reproductive health on cardiovascular outcomes.

Main Methods:

  • This is a review article, synthesizing existing research on reproductive factors and cardiovascular risk.
  • The review examines data on fetal growth, male reproductive health, pregnancy complications, assisted reproductive technologies, and hormonal changes.

Main Results:

  • Low birth weight, erectile dysfunction, and male subfertility are linked to increased hypertension and CVD risk.
  • Hypertensive disorders of pregnancy, like preeclampsia, pose significant risks, though low-dose aspirin may mitigate preeclampsia risk.
  • Reproductive technologies, contraceptive use, and menopausal transitions are also associated with elevated blood pressure.

Conclusions:

  • Reproductive health is a critical, often overlooked, determinant of cardiovascular health across the lifespan.
  • A comprehensive understanding of reproductive influences on hypertension and metabolic abnormalities can enhance CVD risk prediction.
  • Targeted interventions addressing reproductive health factors may offer novel strategies for CVD prevention.